People
Disa Tehler
RNA scientist with biotechnology-engineering and molecular-biology training and extensive academic/pharma experience. Neumirna announced her appointment September23,2026. Abzu affiliation is historical; bankruptcy April2026 and ceased-operation statement prevent a current-employment inference.
Roles
Abzu
CurrentHead of RNA Therapeutics — former, February 2026 roster